Dr. Eri Fukaya, MD

Dr. Fukaya practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Fukaya's NPI, 1831332386, was assigned on April 14, 2009. Dr. Fukaya graduated from Tokyo Women's Medical University in 1999. Dr. Fukaya holds California license A135165.

Dr. Fukaya's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Fukaya's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Fukaya to 1 more hospital, named with a free account. Dr. Fukaya's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fukaya practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Fukaya's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Fukaya is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Fukaya's licenses on file in 3 states: California, Pennsylvania and Ohio.

Dmand AI lists acute skin infection, aneurysm, ankle or foot injury, chronic embolism thrombosis, chronic hypertension, chronic skin ulcer, coronary artery disease and fibromyalgia and chronic pain among the conditions Dr. Fukaya treats.

CMS data shows 1,411 Medicare services from Dr. Fukaya across 20 procedure codes in 2024, for 479 Medicare patients. Medicare paid $108,042 for them.

CMS counts 479 Medicare patients who saw Dr. Fukaya in 2024. The largest group is 65 to 74, with 197 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fukaya's median patient age at 61, with 66% women.

In 2024, Dr. Fukaya wrote 347 Medicare Part D claims for 93 patients. 69% of them were for generic drugs. CMS names the drug for 246 of them, across 11 drugs with 11 or more claims each, at $105,442 in total drug cost. In 2023, CMS named 189 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Fukaya for performance year 2024, reported as part of a group. Dr. Fukaya accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fukaya as offering telehealth. CMS counts 410 procedures of removal of tissue by Dr. Fukaya, more than 96% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 44 papers to Dr. Fukaya, published from 2009 to 2025. 2023 was the busiest year, with 11. The most frequent topics are Venous Insufficiency, Varicose Veins and Saphenous Vein. Dr. Fukaya has published most often in J Vasc Surg Venous Lymphat Disord. Dr. Fukaya's most frequent co-authors are Anand Hemant Athavale, MBBS, Nicholas James Leeper, MD and Venita Chandra, MD.

CMS Open Payments shows 66 general payments to Dr. Fukaya from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Medtronic Vascular, Inc. paid the most, $16,673.

Dr. Fukaya graduated from Tokyo Women's Medical University in 1999.

Dr. Fukaya is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.